Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 2 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 626 pembrolizumab 505 Paclitaxel 456 Gemcitabine 439 Carboplatin 437 Cisplatin 420 Radiotherapy 382 fludarabine 367 Nivolumab 340 Docetaxel 278 Bevacizumab 276 Irinotecan 258 Magnetic Resonance Spectroscopy 245 Fluorouracil 229 Dexamethasone 225 Specimen Handling 222 Capecitabine 218 Rituximab 206 Oxaliplatin 201 Cytarabine 201 Ipilimumab 198 Temozolomide 197 Biopsy 197 fludarabine phosphate 194 Etoposide 181 Lenalidomide 176 Doxorubicin 175 Leucovorin 174 Cetuximab 171 Injections 170

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sulfasalazine × Clear all

NCT04205357 2023-03-03

SAS-GKRS

Haukeland University Hospital

Phase 1 Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡